España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
GSK
GSK
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$36.76
-0.25
-0.68%
At close: -
$36.76
0
0.00%
After Hours: 4:56 PM EDT
15 minutes delayed
Get Report
Comment
Q3 2024 Earnings were released on Wed Oct 30th, before the market open
The most recent conference call was at 8:00 AM, 1 day ago
Click to view past webcast
Chimagen Biosciences announced it will sell assets to GSK (GSK) on Tuesday, October 29, 2024 for $300.0M
GSK (GSK) Forecast
News
Earnings
GSK (GSK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for GSK (NYSE:GSK) Stock
GSK Stock (NYSE: GSK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, October 31, 2024
Guggenheim Downgrades GSK to Neutral
Benzinga Newsdesk
Wednesday, October 30, 2024
USDA Says H5N1 Bird Flu Detected In Swine For...
Benzinga Newsdesk
USDA To Begin Bulk Milk Testing For Bird Flu ...
Benzinga Newsdesk
GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
Vandana Singh
GSK shares are trading lower after the compan...
Benzinga Newsdesk
GSK Reaffirms Its 2024 Outlook, Sees Turnover...
Benzinga Newsdesk
GSK Q3 2024 Adj. EPS $1.29 Beats $1.23 Estima...
Benzinga Newsdesk
Tuesday, October 29, 2024
US CDC Reports 36 H5 Bird Flu Cases In U.S. S...
Benzinga Newsdesk
GSK Acquires CMG1A46 From Chimagen Bioscience...
Benzinga Newsdesk
Monday, October 28, 2024
Google To Launch New "Sexual Health & Wellnes...
Benzinga Newsdesk
IDEAYA Biosciences Reveals Clearance Of Investigational New DrugApplication With FDA For Initiation Of Phase 1 Clinical Trial To Evaluate Werner Helicase Development Candidate IDE275
Suganya Shanmugam
Thursday, October 24, 2024
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
Vandana Singh
CDC Issues Report On Missouri H5N1 Serology T...
Benzinga Newsdesk
GSK Announced New Preliminary Data For Arexvy...
Benzinga Newsdesk
Wednesday, October 23, 2024
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
Vandana Singh
Monday, October 21, 2024
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
GSK, Cambridge University Announced New Five-...
Benzinga Newsdesk
Thursday, October 17, 2024
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Vandana Singh
Wednesday, October 16, 2024
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
Vandana Singh
Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans
Vandana Singh
ViiV Healthcare, Owned By GSK, Pfizer And Shi...
Benzinga Newsdesk
The FDA Has Accepted Us Marketing Application...
Benzinga Newsdesk
Tuesday, October 15, 2024
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
Vandana Singh
GlaxoSmithKline Sues Moderna For U.S. Patent ...
Benzinga Newsdesk
Monday, October 14, 2024
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
Vandana Singh
GSK Says Headline Results From Phase 3 Trials...
Benzinga Newsdesk
Friday, October 11, 2024
State Reports Six Human Bird Flu Cases Now Co...
Benzinga Newsdesk
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
Vandana Singh
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Vandana Singh
Thursday, October 10, 2024
GSK and Pfizer shares are trading lower amid ...
Benzinga Newsdesk
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
Vandana Singh
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
Avi Kapoor
Wednesday, October 09, 2024
GSK Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Vandana Singh
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
Vandana Singh
GSK shares are trading higher after the compa...
Benzinga Newsdesk
GSK plc Shares Resume Trade
Benzinga Newsdesk
GSK Announces Zantac (Ranitidine) Litigation ...
Benzinga Newsdesk
GSK plc Shares Halted, News Pending
Benzinga Newsdesk
Tuesday, October 08, 2024
Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
Vandana Singh
GSK Announced New Data From The AReSVi-006 Ph...
Benzinga Newsdesk
Monday, October 07, 2024
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Vandana Singh
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
GSK, Pfizer And Shionogi-owned ViiV Healthcar...
Benzinga Newsdesk
Friday, October 04, 2024
GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Vandana Singh
U.S. HHS Official Says BARDA Awarding Additio...
Benzinga Newsdesk
Thursday, October 03, 2024
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Vandana Singh
Wednesday, October 02, 2024
World Organization For Animal Health Says Hun...
Benzinga Newsdesk
Tuesday, October 01, 2024
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Kaustubh Bagalkote
Monday, September 30, 2024
World Organization For Animal Health Says Ger...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch